Ricoh’s healthcare solutions are FDA 510 (k) certified for anatomical modeling

Ricoh USA – the American branch of the Japanese giant in the field of digital printing devices and solutions, announced that RICOH 3D for Healthcare has received 510 (k) approval from the US Food and Drug Administration (FDA) for cranio-maxillofacial (CMF) modeling and orthopedic for patients. RICOH 3D for Healthcare is an integrated, end-to-end HIPAA compliant workflow solution for the development, design and production of 3D printed anatomical models. They are manufactured using Stratasys’s 3D printing technology, enabling healthcare professionals to develop tissue and bone models tailored to the patient’s needs.

Precise anatomical replicas help clinicians to see inside the anatomy, providing greater insight into the patient’s needs. RICOH 3D for Healthcare integrates with IBM iConnect Access, IBM Watson Health’s imaging solution used in many US hospitals, making it easy to integrate with your existing workflow. Customers can choose between two options based on their preferred work style or need – the point of care where the Ricoh Managed Services team works on-site or they can order and print models at a Ricoh facility.

According to the North American Radiological Society (RSNA), the use of 3D printing technology to aid in clinical care in the CMF area has become popular since the advent of 3D printing in the late 1980s. Surgeons, engineers and scientists were designing more manual ways to turn medical imaging datasets into 3D models prior to the commercialization of 3D printing technology. According to the report, patient-specific anatomical models are the basis in the CMF sector and more and more work confirms the advantages of 3D printed models. These include better understanding of anatomy and pre-operative planning for complex surgical cases, as well as reducing surgery time and improving patient outcomes.

Ricoh plans to seek FDA approval for additional areas of medical treatment in the future.

Source: www.ricoh-usa.com
Photo: www.prnewswire.com (press materials / all rights reserved)